Internal Medicine, Endocrinology, Diabetes, & Metabolism · Lakeville, MN
NPI
1295132751
Since 2014
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
18465 Orchard Trl
Lakeville, MN, 55044
Phone (952) 428-0950
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
2,579 services
Medicare patients, 2024
337
Average age 70
Drug cost, 2024
$1.6M
3,546 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Akuffo Quarde was code 99214 (office e&m - established), 303 times for 207 patients. In total Akuffo Quarde billed 2,579 services in 33 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 303 | 207 | $65.04 | $20K |
| 95251 Test - Miscellaneous | Facility | 82 | 60 | $26.52 | $2,175 |
| 99215 Office E&M - Established | Facility | 53 | 45 | $99.61 | $5,279 |
| 99204 Office E&M - New | Facility | 49 | 49 | $88.55 | $4,339 |
| 99213 Office E&M - Established | Facility | 42 | 42 | $43.86 | $1,842 |
| 99204 Office E&M - New | Office | 15 | 15 | $121.05 | $1,816 |
| 99203 Office E&M - New | Facility | 14 | 14 | $48.36 | $677 |
By year: 2022 $44K for 613 services; 2023 $40K for 596 services; 2024 $49K for 2,579 services.
Medicare prescription drug claims, 2024
In 2024, the drug Akuffo Quarde prescribed most often to Medicare patients was Levothyroxine Sodium, with 254 prescriptions and refills. In total Akuffo Quarde wrote 3,546 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 254 | 593 | 72 | $2,746 |
| Ozempic Semaglutide | 240 | 326 | 49 | $298K |
| Methimazole Generic | 198 | 314 | 36 | $1,707 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 182 | 317 | 50 | $25K |
| Novolog Flexpen Insulin Aspart | 118 | 162 | 36 | $32K |
| Pioglitazone Hcl Generic | 112 | 247 | 38 | $1,476 |
| Metformin Hcl Generic | 112 | 237 | 27 | $1,223 |
| Trulicity Dulaglutide | 107 | 147 | 28 | $143K |
| Jardiance Empagliflozin | 100 | 135 | 25 | $78K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 94 | 187 | 33 | $41K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 94 | 145 | 16 | $86K |
| Hydrocortisone Generic | 84 | 144 | 17 | $3,319 |
| Novolog Insulin Aspart | 71 | 74 | 11 | $11K |
| Insulin Aspart Flexpen Insulin Aspart | 69 | 78 | 22 | $13K |
| Rybelsus Semaglutide | 68 | 70 | 17 | $67K |
Brand drugs: 1,962 claims; generic drugs: 1,232 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Akuffo Quarde were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.